Skip to main content
. 2019 Jun 21;2(6):e195892. doi: 10.1001/jamanetworkopen.2019.5892

Figure 3. Subgroup Analysis for the Primary Outcome Measure in the Propensity Score–Matched Cohort.

Figure 3.

ACEI indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker; eGFR, estimated glomerular filtration rate; HF, heart failure; HR, hazard ratio; LVEF, left ventricular ejection fraction; MRA, mineralocorticoid receptor antagonist; and NYHA, New York Heart Association.